re: Ann: Appendix 3Y- Change of Director'... muzz
you are way too negative imo
surely you know that small purchases from directors will do nothing in terms of driving the price direction. True the buying may be happening as a show of confidence on the merger but what is wrong with that? When they dont buy we complain, when the buy we complain
you mentioned in another post you have been holding for 8 years, and thus i understand your pain, however never in its history has BTA bene in a position where it can rgress a drug so far with none of its own funds to a level were annual revenue is likely to dwarf its market cap. Even settling with GSK for 100m is pittance vs the upside that is looking likely over the next few years
- Forums
- ASX - By Stock
- BTA
- Ann: Appendix 3Y- Change of Director's Intere
Ann: Appendix 3Y- Change of Director's Intere, page-4
-
- There are more pages in this discussion • 23 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add BTA (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
LGP
LITTLE GREEN PHARMA LTD
Paul Long, CEO
Paul Long
CEO
Previous Video
Next Video
SPONSORED BY The Market Online